IP Verse

Botti patent opposition analysis

The comprehensive analysis of Botti opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Botti

Stay updated with the latest patent oppositions filed by Botti

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3700529
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 9, 2026BOTTI & FERRARI
EP4316598
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 17, 2026BOTTI & FERRARI
EP4294395
Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-0077GENENTECHDec 29, 2025BOTTI & FERRARI
EP3615541
Polymorphs And Solid Forms Of (S)-2-((2-((S)-4-(Difluoromethyl)-2-Oxooxazolidin-3-Yl)-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepin-9-Yl)Amino)Propanamide, And Methods Of ProductionF HOFFMANN LA ROCHEDec 19, 2025BOTTI & FERRARI
EP3246047
Combination DrugCHUGAI SEIYAKU KABUSHIKI KAISHASep 24, 2025BOTTI & FERRARI
EP4069254
Combination Decitabine And Cedazuridine Solid Oral Dosage FormsOTSUKA PHARMACEUTICALJun 11, 2025BOTTI & FERRARI
EP3595667
Pharmaceutical Compositions Comprising A Jak InhibitorGILEAD SCIENCESSep 17, 2024BOTTI & FERRARI
EP3526170
Method For Producing Mineral FibresSAINT GOBAINSep 6, 2024STM
EP2497650
Method For Processing A Structured Surface Of An Embossing ToolHUECK RHEINISCHEJul 11, 2024SESA
EP3500241
Combination Therapy For CopdCHIESI FARMACEUTICIJul 3, 2024BOTTI & FERRARI

Top clients of Botti

Top companies who are the clients of Botti

CompanyTotal
BOTTI & FERRARI14
STM6
TACO ITALIA2
SESA1